PSY THERAPEUTICS
Psy Therapeutics is discovering and developing novel medicines to improve the lives of people affected by central nervous system (CNS) disorders.
PSY THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care
Founded:
2012-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.psythx.com
Total Employee:
11+
Status:
Active
Contact:
(617) 723-5429
Total Funding:
3.97 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
WPSS.bio
WPSS.bio investment in Seed Round - Psy Therapeutics
Official Site Inspections
http://www.psythx.com Semrush global rank: 9.68 M Semrush visits lastest month: 116
- Host name: ec2-23-21-140-252.compute-1.amazonaws.com
- IP address: 23.21.140.252
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Psy Therapeutics"
Psy Therapeutics - Drug discovery for central nervous system …
Psy is addressing critical neuropsychiatric needs through innovation, proven expertise and deep commitment . Significantly improved therapies for CNS disorders are within reach.See details»
Our team is creating new futures in CNS …
Psy Therapeutics team of executives and neuropsychiatric leaders have a proven ability to create significant and sustained value for patients and investorsSee details»
Psy Therapeutics - Crunchbase Company Profile & Funding
PSY-05001: A non-addictive analgesic for effective pain management without the risk of misuse, currently in IND-enabling studies. PSY-05: A development candidate for Generalized Anxiety …See details»
Psy Therapeutics - BIO International Convention 2025
Psy Therapeutics discovers and develops innovative medicines for neuropsychiatric and neurological disorders, including PTSD, depression, Chronic Pain, Alzheimer’s, and Parkinson’s.See details»
Psy Therapeutics - VentureRadar
Our approach is to create a research-focused organization dedicated to generating novel intellectual property around improved versions of these former best-selling drugs. We have a …See details»
Our Approach - Psy Therapeutics
We are discovering and developing a robust pipeline of high potential drug candidates through our risk-contained approach which focuses on validated targets, engages leading experts …See details»
Psy Therapeutics, Inc. | CipherBio
Explore Psy Therapeutics, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Psy Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore Psy Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Chemical ...See details»
Psy Therapeutics - Overview, News & Similar companies - ZoomInfo
Psy Therapeutics contact info: Phone number: (617) 723-5429 Website: www.psythx.com What does Psy Therapeutics do? Psy Therapeutics is deeply committed to discovering and …See details»
David S. Barlow - Psy Therapeutics
David is deeply committed to improving the lives of people affected by central nervous system (CNS) disease. By combining that focus with his proven ability to build companies that create significant enterprise value, David is guiding Psy …See details»
Psy Therapeutics – Funding, Valuation, Investors, News
Essential stats, news, real-time insights on Psy Therapeutics. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Psy Therapeutics Overview | SignalHire Company Profile
Organization Website. psythx.com . Social Links. Psy Therapeutics industries. Biotech Psy Therapeutics Employees Size. 10-50 employees ...See details»
Psy Therapeutics to Present at the Virtual Life Science Investor …
Mar 10, 2025 Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com. BOSTON, March 10, 2025 …See details»
Psy Therapeutics: Contact Us
Want to learn more about partnering with Psy THerapeutics? Contact us and our various departments by filling out the contact us form.See details»
Psy Therapeutics to Present at the Virtual Life Science Investor …
Mar 10, 2025 [email protected]. Virtual Investor Conferences John M. Viglotti SVP Corporate Services, Investor Access OTC Markets Group (212) 220-2221 …See details»
Psy Therapeutics, Inc. (Psy Therapeutics, Inc.) - 药物管线_专利_临床 …
了解Psy Therapeutics, Inc. (Psy Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:神经系统疾病，技术平台:化学药，药物:PSY-05001，PSY-05，PSY …See details»
Pipeline - Psy Therapeutics
Psy’s value-creating pipeline consists of compelling risk-balanced programs which address significant unmet needs in CNS. Each program applies tailored, cutting-edge technologies to …See details»
PsycheX Home Page
PsycheX the future PSY. PsycheX transcends being a token, serving as a bridge between consciousness and technology, uniting the digital with the metaphysical and the material with …See details»
Psy Therapeutics to Present at the Virtual Life Science Investor …
Mar 10, 2025 [email protected]. Virtual Investor Conferences John M. Viglotti SVP Corporate Services, Investor Access OTC Markets Group (212) 220-2221 …See details»
Partners - Psy Therapeutics - psythx.com
Sai Life Sciences is a full-service contract development and manufacturing organization (CDMO) with a vision to propel the launch of 25 new medicines by 2025. Sai works with innovator …See details»